Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 63
Filtrar
1.
J Cereb Blood Flow Metab ; 11(6): 1031-5, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1939381

RESUMEN

We retrospectively examined arerial and end-tidal estimations of CO2 tension used to calculate cerebrovascular reactivity in 68 anesthetized patients. CBF was measured using the intravenous 133Xe technique at mean +/- SD PaCO2 values of 28.2 +/- 5.2 and 38.8 +/- 4.8 mm Hg. The correlation between all PaCO2 and end-tidal PCO2 (PetCO2) values was y = 0.85x - 0.49 (r = 0.93, p = 0.0001). There was a moderate correlation between age and the difference between PaCO2 and PetCO2 (y = 0.11x + 0.79; r = 0.73, p = 0.0001). Cerebrovascular reactivity to changes in CO2 (ml 100 g-1 min-1 mm Hg-1) was similar (p = 0.358) when calculated by using either PaCO2 (1.9 +/- 0.8) or PetCO2 (1.8 +/- 0.8) and highly correlated (y = 0.86x + 0.23; r = 0.91, p = 0.0001). The CBF response to changes in CO2 tension can be reliably estimated from noninvasive measurement of PetCO2.


Asunto(s)
Dióxido de Carbono/sangre , Circulación Cerebrovascular/fisiología , Respiración , Adulto , Anciano , Envejecimiento/fisiología , Arterias , Humanos , Persona de Mediana Edad , Presión Parcial , Estudios Retrospectivos , Volumen de Ventilación Pulmonar
2.
Spine (Phila Pa 1976) ; 3(2): 171-4, 1978 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-663768

RESUMEN

Deliberate induced hypotension for spinal fusion has been used in the past, but a search for better techniques continues. The authors used sodium nitroprusside by intravenous infusion to reduce the mean arterial pressure from 72 to 42 torr in 10 cases. This degree of hypotension provided an optimal surgical field and maintained adequate tissue perfusion as demonstrated by arterial oxygen tensions greater than 600 torr, no development of base deficit, and continuous urinary excretion. There were no complications related to hypotension. None of the patients received blood transfusions, whereas in the past, 2000 ml blood was usually required for this procedure.


Asunto(s)
Ferricianuros , Hipotensión Controlada , Nitroprusiato , Fusión Vertebral , Adulto , Anestesia por Inhalación , Femenino , Ferricianuros/administración & dosificación , Humanos , Inyecciones Intravenosas , Masculino , Nitroprusiato/administración & dosificación
3.
J Neurosurg Anesthesiol ; 2(1): 23-7, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15815313

RESUMEN

Hyperglycemia, even if mild, is known to aggravate neuronal damage from cerebral ischemia. In order better to define the influence of currently used anesthetic techniques on plasma glucose levels during cerebrovascular surgery, we examined serial plasma glucose values during 43 carotid endarterectomies (CEA) and 19 intracranial arteriovenous malformation (AVM) resections. CEA patients (aged 67.6 +/- 1.4 years and weighing 76.4 +/- 2.3 kg, mean +/- SEM) received N2O in O2 and either isoflurane (ISO) (n = 14), halothane (n = 8), fentanyl (n = 10), or sufentanil (n = 11). Plasma glucose was compared at 1.12 +/- 0.05 h (stage 1), 2.08 +/- 0.07 h (stage 2), and 3.12 +/- 0.1 h (stage 3) after induction of anesthesia. AVM patients received ISO and N2O in O2. Plasma glucose was compared 2.32 +/- 0.14 h (stage 1) and 6.25 +/- 0.34 h (stage 2) after induction of anesthesia (surgical stage). Glucose was determined by the hexokinase method. In the CEA cases, progressively elevated plasma glucose levels were associated with successive surgical stage (114 +/- 6, 122 +/- 6, and 138 +/- 6 mg/dl). The seven CEA patients that carried the diagnosis of diabetes mellitus tended to have higher glucose levels but they did not differ significantly from nondiabetic patients. The AVM patients (aged 35.7 +/- 2.3 years and weighing 71.1 +/- 2.9 kg) were all nondiabetic. They were significantly younger than the CEA patients and each received dexamethasone intraoperatively. In these patients, there was a significant effect (p <0.04) of surgical stage to increase plasma glucose (115 +/- 10 vs. 126 +/- 10 mg/dl). For CEA, the anesthetic techniques examined do not differ significantly in their influence on plasma glucose levels, but all techniques were associated with a gradual increase in plasma glucose levels intraoperatively, even in nondiabetic patients. Compared to the group of younger AVM patients, glucose elevation was more pronounced in the elderly CEA patients. We conclude that intraoperative monitoring of plasma glucose may be useful in elderly patients during prolonged neurovascular procedures.

4.
J Clin Anesth ; 1(1): 31-5, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-2908483

RESUMEN

Twenty-five patients scheduled for lumbar fusion or cerebrovascular surgery were enrolled in an open label treatment controlled study comparing blood pressure and heart rate responses during deliberate hypotension with either esmolol or nitroprusside during steady-state N2O/isoflurane anesthesia. The first 5 patients were empirically assigned to the esmolol group; the remaining 20 patients were randomized to receive either esmolol or nitroprusside. The target of 15% reduction in mean arterial pressure (MAP) from baseline determined during anesthesia was attained with esmolol 195 +/- 10 micrograms/kg/min (mean +/- SEM) for the group (n = 15) or nitroprusside 1.9 +/- 0.3 micrograms/kg/min for the nitroprusside group (n = 10). Nitroprusside use was associated with a 15.9 +/- 5.3% increase in heart rate compared to a 12.1 +/- 2.2% decrease in the esmolol group (p = 0.0001 between groups). Upon termination of the hypotensive infusions, nitroprusside patients had a MAP increase of 13.9 +/- 5.5% above baseline (p less than 0.05 compared to prehypotension) while the 7.4 +/- 3.5% increase in the esmolol group was not statistically significant. Although 30% of nitroprusside patients overshot their baseline MAP by more than 25%, no esmolol patients had this degree of rebound. One esmolol patient had a brief period of atrial premature contractions. No patient in either group suffered any adverse reaction to hypotension. It is concluded that in moderate doses esmolol is a safe and effective hypotensive agent during isoflurane anesthesia, with no reflex tachycardia and no significant potential for rebound hypertension. A MAP reduction of 30% from preanesthesia baseline was readily obtained with this combination.


Asunto(s)
Antagonistas Adrenérgicos beta , Propanolaminas , Antagonistas Adrenérgicos beta/farmacología , Anestesia General , Presión Sanguínea/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Neurocirugia , Nitroprusiato/farmacología , Propanolaminas/farmacología , Ensayos Clínicos Controlados Aleatorios como Asunto , Fusión Vertebral , Procedimientos Quirúrgicos Vasculares
5.
J Clin Anesth ; 3(2): 108-11, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1828161

RESUMEN

STUDY OBJECTIVE: To determine whether a drug interaction exists between doxacurium and anticonvulsants. DESIGN: Open-label controlled study. SETTING: Inpatient neuroanesthesiology service at a university medical center. PATIENTS: Three groups of nine patients each, consisting of those chronically receiving carbamazepine, phenytoin, or no anticonvulsant therapy. INTERVENTION: Intravenous administration of doxacurium 60 micrograms/kg during anesthesia with nitrous oxide (N2O), fentanyl, and droperidol. MEASUREMENTS AND MAIN RESULTS: The adductor pollicis mechanical response to single 0.2-millisecond supramaximal pulses delivered to the ulnar nerve at 0.15 Hz was recorded. Patients receiving phenytoin or carbamazepine recovered neuromuscular function more quickly than did the control group. The times from doxacurium injection to 50% recovery of mechanomyographic response, for example, were as follows: control group, 161 +/- 55 minutes (mean +/- SD); phenytoin group, 76 +/- 31 minutes; and carbamazepine group, 66 +/- 27 minutes (p less than 0.05). The time for recovery from 75% to 25% blockade (recovery index) was decreased by 53% in the phenytoin group and by 67% in the carbamazepine group as compared with the control group (41.0 +/- 18.0 minutes and 28.6 +/- 8.6 minutes vs 86.4 +/- 45.2 minutes, respectively). CONCLUSION: Chronic treatment with anticonvulsants results in more rapid recovery from neuromuscular blockade produced by doxacurium.


Asunto(s)
Carbamazepina/farmacología , Isoquinolinas/antagonistas & inhibidores , Unión Neuromuscular/efectos de los fármacos , Fármacos Neuromusculares no Despolarizantes/antagonistas & inhibidores , Fenitoína/farmacología , Adulto , Periodo de Recuperación de la Anestesia , Interacciones Farmacológicas , Humanos , Persona de Mediana Edad
7.
Anesth Analg ; 64(8): 767-72, 1985 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3160262

RESUMEN

Responses to the nondepolarizing muscle relaxant, metocurine, were studied in eight hemiplegic and eight unmatched patients with normal motor strength during the general anesthetic given for various neurosurgical operations. Metocurine, 0.3 mg/kg, was administered intravenously, and indirectly evoked thumb twitch tensions were measured on both sides in the hemiplegic patients, and on one side in the normal patients. Arterial blood samples were obtained as twitch tension was recovering, and serum metocurine concentrations were determined using a specific radioimmunoassay. Percentage of paralysis was plotted as a function of log [metocurine] and the data were compared by analysis of covariance. For the normal motor strength patients, r = 0.84; for the unaffected arm of the hemiplegic patients, r = 0.69; and for the affected arm of the hemiplegic patients, r = 0.86, all significant at P less than 0.001. The mean plasma metocurine concentrations at 20, 25, 50, 75, and 80% paralysis were significantly different for all groups (P less than 0.001). The regression lines, in turn, did not overlap and were significantly different, each from the other (P less than 0.005). We were, however, unable to detect any significant deviation from parallelism among the three regression lines. We also measured time to 50% return of single twitch height for each data group as follows (mean +/- SEM: for NMS patients, 242 +/- 73 min; for the unaffected arm of hemiplegic patients, 116 +/- 60 min; and for the affected arm of hemiplegic patients, 59 +/- 36 min. By ANOVA and the Bonferroni test, each value was different from the other at P less than or equal to 0.01.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Neuronas Motoras , Enfermedades Neuromusculares/fisiopatología , Fármacos Neuromusculares no Despolarizantes/farmacología , Tubocurarina/análogos & derivados , Adulto , Anciano , Hemiplejía/fisiopatología , Humanos , Persona de Mediana Edad , Contracción Muscular/efectos de los fármacos , Fármacos Neuromusculares no Despolarizantes/sangre , Radioinmunoensayo , Estadística como Asunto , Tubocurarina/sangre , Tubocurarina/farmacología
8.
Anesthesiology ; 55(3): 273-6, 1981 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7023284

RESUMEN

The pharmacodynamics and pharmacokinetics of metocurine were studied in five neurosurgical patients with normal renal function, and in five anephric patients during and following a renal transplant. Following a single intravenous dose of metocurine (0.3 mg/kg), measurements of serum levels and urinary excretion were made using a specific radioimmunoassay for metocurine. Evoked compound electromyographic (ECEMG) response of the thumb adductor to supramaximal stimulation of the ulnar nerve was also studied. In the patients for renal transplant, plasma clearance of metocurine was significantly reduced (0.38 vs. 1.2 ml . kg-1 . min-1, P less than 0.01) and the elimination half-life was significantly prolonged (11.4 vs. 6.0 h, P less than 0.01). The higher serum concentration of metocurine in patients for renal transplant was accounted for by the absence of renal excretion and a reduced total volume of distribution (0.353 vs. 0.472 l/kg, P less than 0.05). The mean serum metocurine concentration necessary for 90 per cent inhibition of the ECEMG was 2.3 times greater in patients undergoing renal transplant than in patients undergoing craniotomy, 1.05 vs. 0.46 microgram/ml (P less than 0.01). Although serum metocurine concentrations were still high at the end of the renal transplants, reversal of the neuromuscular blockade was possible. Metocurine appears to be an acceptable neuromuscular blocking agent for patients in renal failure although no major advantage over d-tubocurarine and pancuronium could be found.


Asunto(s)
Fallo Renal Crónico/tratamiento farmacológico , Tubocurarina/análogos & derivados , Adulto , Craneotomía , Potenciales Evocados , Humanos , Trasplante de Riñón , Cinética , Tubocurarina/metabolismo , Tubocurarina/uso terapéutico , Nervio Cubital/efectos de los fármacos
9.
Artículo en Inglés | MEDLINE | ID: mdl-6520044

RESUMEN

Ten dogs developed unilateral gastrocnemius disuse atrophy after unilateral hindlimb immobilization in a cast for 25 days. Dose-response curves to dimethyl tubocurarine (MTC) were determined during anesthesia with pentobarbital sodium-N2O. Bolus and continuous infusion increments of MTC every 30 min provided steady-state blood levels at each stage of paralysis. Both gastrocnemius tendons were sectioned and attached to transducers. Both sciatic nerves were stimulated every 30 min: 2 Hz for 2 s, a 15-s pause, 50 Hz for 2 s. Dose-response curves, computer calculated by nonlinear regression using a sigmoid maximal effect model of the Hill equation, were parallel for the data relating blocking of tetanus to dose of MTC. The 50% paralyzing dose (tetanus) for control vs. casted gastrocnemius muscle was 64 vs. 813 mg/kg; corresponding plasma concentrations were 0.12 vs. 2.0 micrograms/ml. Thus in vivo simultaneous tension measurements of both gastrocnemius muscles, one casted and one uncasted, demonstrated resistance to paralysis by MTC in muscle with disuse atrophy.


Asunto(s)
Inmovilización , Atrofia Muscular/fisiopatología , Parálisis/inducido químicamente , Tubocurarina/análogos & derivados , Animales , Perros , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Pierna , Atrofia Muscular/etiología , Tubocurarina/sangre , Tubocurarina/farmacología
10.
Anesth Analg ; 62(2): 160-3, 1983 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-6829917

RESUMEN

Combination of pancuronium (Pm) with d-tubocurarine (dTC) or metocurine (mTC) produces potentiation of neuromuscular effects. We tested the hypothesis that this effect is due to decreased plasma protein and/or nonspecific (noncholinergic) tissue binding by one or the other drug such that a greater than expected proportion of unbound drug reaches its neuromuscular site of activity. By varying the concentration of Pm, dTC, and mTC, competitive binding by Pm and dTC or Pm and mTC to plasma constituents was tested in vitro by equilibrium dialysis. Drug interaction and displacement from nonspecific binding sites in tissues was tested in vivo with Pm-mTC combinations. During recovery of mTC-induced neuromuscular paralysis, monitored by evoked twitch tension, 1 mg of Pm was administered intravenously. The twitch height and plasma mTC concentrations before and after Pm administration were noted. The in vitro plasma dTC or mTC binding was not significantly altered by the addition of Pm. Similarly, plasma mTC concentrations in vivo did not increase following the administration of Pm. Thus, there was no displacement of mTC from nonspecific tissue binding sites by Pm. Our in vitro and in vivo experiments both demonstrate that there is no interaction between Pm--dTC and Pm--mTC relative to plasma or tissue binding and thus cannot explain the potentiating effect of the drug combination.


Asunto(s)
Relajantes Musculares Centrales/farmacología , Unión Competitiva/efectos de los fármacos , Interacciones Farmacológicas , Sinergismo Farmacológico , Humanos , Técnicas In Vitro , Relajantes Musculares Centrales/sangre
11.
Anesthesiology ; 45(5): 508-15, 1976 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-973707

RESUMEN

Pulmonary shunting (Qs/Qt with FIO2 = 1) was measured in 18 anesthetized patients during deliberate hypotension. Hypotension was induced in 12 patients with sodium nitroprusside and light halothane anesthesia and in six others with deep halothane anesthesia and mechanical hyperventilation. Similar results were observed in the two groups. During the hypotensive period mean arterial pressure (MAP) was reduced to 49 +/- 2 torr, a 37 per cent decrease from the control level after the onset of operation and a 40 per cent decrease compared with the recovery level during closure of the wound. Qs/Qt, however, remained unchanged throughout the study: 5.2 +/- 0.9 per cent initially, 5.4 +/- 0.8 per cent during hypotension, and 4.7 +/- 0.5 per cent during recovery. It is concluded that pulmonary shunting need not develop during deliberate hypotension induced with either technique.


Asunto(s)
Anestesia por Inhalación , Hipotensión Controlada , Respiración , Adulto , Presión Sanguínea/efectos de los fármacos , Halotano , Humanos , Nitroprusiato/uso terapéutico , Consumo de Oxígeno , Circulación Pulmonar , Respiración Artificial , Relación Ventilacion-Perfusión
12.
Anesth Analg ; 67(8): 775-8, 1988 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3394965

RESUMEN

This study was undertaken to assess differences between young and elderly patients with respect to the duration of antagonism of metocurine neuromuscular blockade by neostigmine (NEO) or pyridostigmine (PYR). Patients were given either NEO (seven elderly and ten young) or PYR (seven elderly and eight young) and received nitrous oxide in oxygen (60:40) and 1 MAC halothane. Neuromuscular transmission was assessed by using evoked compound electromyography. Metocurine 0.1 mg/kg was given, followed by a continuous infusion to achieve 90% reduction in baseline single twitch height. After at least 30 minutes, either NEO (0.07 mg/kg) or PYR (0.14 mg/kg) and atropine (0.02 mg/kg) were given IV. After injection of NEO or PYR, the duration of maximal response (DOMR) was recorded. Mean (+/- SE) ages were 38 +/- 5 and 68 +/- 2 years in the two groups of patients receiving PYR. In the elderly, PYR significantly prolonged DOMR compared to younger patients (35.3 +/- 8.2 vs 14.4 +/- 4.2 minutes, respectively). The mean ages in the two groups of patients receiving NEO were 41.5 +/- 4 and 72 +/- 2 years. The elderly group demonstrated a significant increase in the DOMR compared to younger patients (32 +/- 10 vs 11 +/- 2 minutes, respectively). It is concluded that, compared to younger patients, the duration of action of NEO and PYR in the aged patient is prolonged.


Asunto(s)
Envejecimiento/fisiología , Neostigmina/farmacología , Bromuro de Piridostigmina/farmacología , Tubocurarina/análogos & derivados , Adulto , Anciano , Humanos , Inyecciones Intravenosas , Factores de Tiempo , Tubocurarina/antagonistas & inhibidores
13.
Anesthesiology ; 63(3): 294-8, 1985 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-3161430

RESUMEN

Recent reports have described resistance to pancuronium-induced neuromuscular blockade in patients chronically receiving anticonvulsants. This study examines the pharmacokinetics and pharmacodynamics of metocurine (MTC) in 12 patients undergoing craniotomy--six on chronic phenytoin therapy and six comparable controls. Each patient received MTC 0.2 mg/kg during the induction of general anesthesia. Quantification of plasma MTC concentration was performed by radioimmunoassay, while the response to MTC was evaluated by evoked compound electromyography (ECEMG). Patients in the phenytoin group were resistant to this dosage of MTC, as demonstrated by their response (83 +/- 16% compared with 98 +/- 2% depression of ECEMG in control patients, P less than 0.05) and by recovery index, defined as the time required for recovery from 25 to 75% of the control ECEMG (53 +/- 22 min compared with 125 +/- 54 min in control patients, P less than 0.01). Similarly, the total duration of neuromuscular blockade, measured to recovery to 90% of control ECEMG, was significantly shorter in the phenytoin group (122 +/- 25 min compared with 269 +/- 64 min in the control group, P less than 0.01). Plasma concentration-time curves were fit to biexponential equations for both groups. These were used to generate two-compartment models. Neither the model parameters nor the plasma concentrations of MTC at any time in the study were significantly different for the two groups. The pharmacodynamic analysis, however, showed that patients on phenytoin require a higher plasma concentration of MTC (0.415 +/- 0.095 microgram/ml compared with 0.249 +/- 0.066 microgram/ml in control patients at 50% ECEMG, P less than 0.01) to effect a given level of neuromuscular blockade.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Fármacos Neuromusculares no Despolarizantes/antagonistas & inhibidores , Fenitoína/farmacología , Tubocurarina/análogos & derivados , Adulto , Resistencia a Medicamentos , Electromiografía/métodos , Potenciales Evocados/efectos de los fármacos , Humanos , Cinética , Persona de Mediana Edad , Modelos Biológicos , Fármacos Neuromusculares no Despolarizantes/sangre , Tubocurarina/antagonistas & inhibidores , Tubocurarina/sangre
14.
Anesth Analg ; 63(2): 125-8, 1984 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-6691577

RESUMEN

Hypotension was induced in sixteen patients with nitroprusside during anesthesia for surgical correction of cerebral aneurysms. Eight patients were premedicated with propranolol (180 mg orally) for one day and the other eight were not. Before the start of anesthesia, the untreated patients had a mean arterial pressure of 102 +/- 3 mm Hg, a heart rate of 76 +/- 2 beats/min, and plasma epinephrine and norepinephrine concentrations of 114 +/- 21 and 258 +/- 34 pg/ml, respectively. The propranolol-premedicated patients came to the operating room in a significantly different clinical state with a mean arterial pressure of 92 +/- 3 mm Hg, a heart rate of 71 +/- 2 beats/min, and plasma epinephrine and norepinephrine concentrations of 76 +/- 28 and 144 +/- 28 pg/ml. During induced hypotension, plasma epinephrine and norepinephrine concentrations increased significantly in both groups (454 +/- 42 and 730 +/- 58 pg/ml in the untreated patients, 160 +/- 48 and 419 +/- 67 pg/ml in the propranolol premedicated patients), but the increase in catecholamines was significantly greater in the untreated patients. Thirty minutes after nitroprusside was discontinued, epinephrine and norepinephrine concentrations were higher than in the awake state in untreated patients and were associated with rebound hypertension and tachycardia. In contrast, in propranolol-premedicated patients, plasma epinephrine and norepinephrine concentrations decreased towards the preanesthesia values, mean arterial pressure gradually returned to the prehypotension level, and heart rate remained unchanged. This study thus demonstrates that propranolol premedication attenuates the release of catecholamines in response to nitroprusside-induced hypotension.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Ferricianuros , Hipotensión Controlada , Nitroprusiato , Medicación Preanestésica , Propranolol/farmacología , Adulto , Catecolaminas/sangre , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Persona de Mediana Edad , Propranolol/administración & dosificación
15.
Anesth Analg ; 63(9): 799-804, 1984 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6465573

RESUMEN

The relation of plasma concentration of d-tubocurarine (dTc) to neuromuscular blockade, and the distribution and urinary excretion of dTc was determined in neonates (n = 4), infants (n = 6), children (n = 8), and adults (n = 8). The plasma concentration-time course curves to 24 hr are best described for all groups by three-compartment models. Both neonates and infants exhibit decreased plasma clearance (CLP), 1.1 +/- 0.08 and 1.0 +/- 0.06 ml X kg-1 X min-1, and in addition a prolonged t1/2 terminal phase, 311 +/- 44 and 306 +/- 35 (mean +/- SEM, min). The neonates' 24-hr urinary excretion, 27 +/- 2 (mean +/- SEM, % total dose) is significantly less than the adult value, 45 +/- 4% total dose. There was no significant difference seen in the log plasma concentration-evoked compound electromyogram (ECEMG) response between 20-80% paralysis for adults, children, infants, and five of the seven neonates studied. Two of the neonates had a significant shift of their log concentration-response curve to the right. There was also no significant difference between any of the groups in the time for 50% return of ECEMG stimulus height or the time required for recovery of the ECEMG from 25 to 75% of control value. for recovery of the ECEMG from 25 to 75% of control value.


Asunto(s)
Envejecimiento , Tubocurarina/metabolismo , Adulto , Preescolar , Electromiografía , Humanos , Lactante , Recién Nacido , Inyecciones Intravenosas , Cinética , Unión Neuromuscular/efectos de los fármacos , Tubocurarina/farmacología
16.
Anesth Analg ; 74(6): 841-4, 1992 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1317685

RESUMEN

The neuromuscular response to pipecuronium bromide (Arduan), 70 micrograms/kg, was studied in 20 elderly (greater than 70 yr) and 10 younger patients (less than 60 yr) during nitrous oxide, fentanyl, and droperidol anesthesia. The adductor pollicis response to single 0.2-ms supramaximal pulses was recorded. Although all younger patients were completely paralyzed, 2 of 20 elderly patients did not attain 90% paralysis. Onset time in the elderly was prolonged (6.9 +/- 2.6 vs 4.3 +/- 1.5 min, P less than 0.02). Spontaneous recovery was similar in both groups, with 75% recovery occurring at 133 +/- 52 min in the elderly and 146 +/- 46 min in the younger patients. The pharmacokinetic variables were similar for the two groups, and pharmacodynamic analysis revealed a similar sensitivity at the neuromuscular junction. The pharmacologic actions of pipecuronium in otherwise healthy patients do not differ between young and elderly adults.


Asunto(s)
Envejecimiento/metabolismo , Androstano-3,17-diol/análogos & derivados , Fármacos Neuromusculares no Despolarizantes/farmacocinética , Piperazinas/farmacocinética , Procedimientos Quirúrgicos Operativos , Anciano , Envejecimiento/fisiología , Androstano-3,17-diol/farmacocinética , Androstano-3,17-diol/farmacología , Humanos , Persona de Mediana Edad , Relajantes Musculares Centrales/farmacocinética , Relajantes Musculares Centrales/farmacología , Unión Neuromuscular/efectos de los fármacos , Fármacos Neuromusculares no Despolarizantes/farmacología , Pipecuronio , Piperazinas/farmacología , Sensibilidad y Especificidad
17.
Anesth Analg ; 74(4): 515-8, 1992 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1348166

RESUMEN

The effect of obesity on the disposition and action of vecuronium was studied in 14 surgical patients. After induction of anesthesia with thiopental and maintenance of anesthesia by inhalation of nitrous oxide and halothane, seven obese patients (93.4 +/- 13.9 kg, 166% +/- 30% of ideal body weight, mean +/- SD) and seven control patients (60.9 +/- 12.3 kg, 93% +/- 6% of ideal body weight) received 0.1 mg/kg of vecuronium. Plasma arterial concentrations of muscle relaxant were determined at 1, 3, 5, 10, 15, 20, 30, 45, 60, 90, 120, 150, 180, 210, 240, 300, and 360 min by a spectrofluorometric method. Simultaneously, neuromuscular blockade was assessed by stimulation of the ulnar nerve and quantification of thumb adductor response. Times to 50% recovery of twitch were longer in the obese than in the control patients (75 +/- 8 versus 46 +/- 8 min) as were 5%-25% recovery times (14.9 +/- 4.0 versus 10.0 +/- 1.7 min) and 25%-75% recovery times (38.4 +/- 13.8 versus 16.7 +/- 10.3 min). However, vecuronium pharmacokinetics were similar for both groups. When the data were calculated on the basis of ideal body weight (IBW) for obese and control patients, total volume of distribution (791 +/- 303 versus 919 +/- 360 mL/kg IBW), plasma clearance (4.65 +/- 0.89 versus 5.02 +/- 1.13 mL.min-1.kg IBW-1), and elimination half-life (119 +/- 43 versus 133 +/- 57 min) were not different between groups.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Obesidad/metabolismo , Bromuro de Vecuronio/farmacocinética , Adulto , Peso Corporal/fisiología , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Operativos , Bromuro de Vecuronio/farmacología
18.
Can J Anaesth ; 38(8): 965-8, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1752017

RESUMEN

The metabolism of isoflurane and the investigational volatile anaesthetic desflurane to fluoride ion was examined in 25 surgical patients. The patients were randomly assigned to four groups, to receive isoflurane or desflurane at either 0.65 MAC or 1.25 MAC. Anaesthesia was induced in all patients with thiopentone and midazolam and included nitrous oxide 60% in addition to the volatile agent. Blood was drawn before induction and at the end of the operation for determination of serum fluoride ion concentration. Plasma fluoride ion concentrations increased (+ 1.36 +/- 0.93 microM, P less than 0.01) in patients receiving isoflurane but were unchanged (-0.13 +/- 0.50 microM) in patients receiving desflurane. Metabolic release of fluoride ion is less with desflurane than with isoflurane during administration of the anaesthetics to surgical patients, and is unlikely to be of clinical significance.


Asunto(s)
Anestesia por Inhalación , Anestésicos/metabolismo , Fluoruros/sangre , Isoflurano/análogos & derivados , Isoflurano/metabolismo , Adulto , Anestesia por Inhalación/métodos , Anestésicos/administración & dosificación , Desflurano , Femenino , Humanos , Isoflurano/administración & dosificación , Masculino , Persona de Mediana Edad , Óxido Nitroso , Oxígeno , Procedimientos Quirúrgicos Operativos , Factores de Tiempo
19.
Anesth Analg ; 73(6): 790-3, 1991 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1835321

RESUMEN

The pharmacokinetics of sufentanil were determined in eight obese (94.1 +/- 14 kg, mean +/- SD) and eight control patients (70.1 +/- 13 kg) anesthetized for neurosurgery. After induction of anesthesia, 4 micrograms/kg of sufentanil was administered in a single intravenous bolus. Multiple arterial samples were obtained at timed intervals over 6 h, and plasma concentrations of sufentanil were measured by radioimmunoassay. Calculation of pharmacokinetic variables from the derived compartmental models demonstrated an increased volume of distribution of sufentanil in the obese (9098 +/- 2793 mL/kg ideal body weight, mean +/- SD) when compared with a control group (5073 +/- 1673 mL/kg ideal body weight) (P less than 0.01) and a prolonged elimination half-life (208 +/- 82 min vs 135 +/- 42 min, P less than 0.05). The total volume of distribution correlated linearly with the degree of obesity, as expressed in percent ideal body weight (r = 0.67). In contrast, plasma clearance was similar in both obese and control groups (32.9 +/- 12.5 vs 26.4 +/- 5.7 mL/kg ideal body weight). The high lipid solubility of sufentanil probably explains the altered pharmacokinetics of this opioid in obese patients.


Asunto(s)
Analgésicos/farmacocinética , Fentanilo/análogos & derivados , Obesidad/metabolismo , Adulto , Analgésicos/sangre , Femenino , Fentanilo/sangre , Fentanilo/farmacocinética , Semivida , Humanos , Inyecciones Intravenosas , Masculino , Persona de Mediana Edad , Radioinmunoensayo , Sufentanilo
20.
Anesth Analg ; 73(1): 39-42, 1991 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1677546

RESUMEN

The effects of age on the pharmacokinetics and pharmacodynamics of vecuronium in eight elderly patients aged 72-86 yr and eight younger adults aged 26-48 yr undergoing elective surgical procedures under nitrous oxide-fentanyl anesthesia were studied. Vecuronium (0.1 mg/kg) was given as an intravenous bolus, and the ulnar nerve was stimulated with a square-wave impulse of 0.2-ms duration. The response to stimulation at a frequency of 0.1 Hz was measured and recorded with a force displacement transducer applied to the thumb. Spontaneous recovery was significantly longer in elderly patients than in younger patients (50% recovery time, 97.1 +/- 29 vs 39.8 +/- 14 min, mean +/- SD; recovery index [25%-75%], 49.4 +/- 11 vs 15.0 +/- 8 min). In addition, in elderly patients elimination half-life of vecuronium was significantly prolonged (125 +/- 55 vs 78 +/- 21 min, P = 0.04) and plasma clearance reduced (2.6 +/- 0.6 vs 5.6 +/- 3.2 mL.kg-1.min-1, P = 0.049). The prolonged duration of action of vecuronium in the elderly surgical patients thus appears to be secondary to altered pharmacokinetics consistent with an age-related decrease in renal and hepatic functions.


Asunto(s)
Envejecimiento/metabolismo , Bromuro de Vecuronio/farmacocinética , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento/efectos de los fármacos , Anestesia , Fentanilo , Humanos , Persona de Mediana Edad , Óxido Nitroso , Procedimientos Quirúrgicos Operativos , Bromuro de Vecuronio/sangre , Bromuro de Vecuronio/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA